StockData
Tectonic Therapeutic, Inc. logo

Tectonic Therapeutic, Inc. (TECX) stock

TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$21.04+0.96 (+4.78%)

Close on Nov 18, 2026Market cap $411.32MP/E –Yield 0.00%

Tectonic Therapeutic free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Tectonic Therapeutic's free cash flow for the twelve months ending Jun 30, 2026 was -$72.42M. For fiscal 2025 it was -$60.29M. The highest annual figure on record is -$16.77M in fiscal 2017.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$60.29M–
FY2024Dec 31, 2024-$59.24M–
FY2023Dec 31, 2023-$40.96M–
FY2022Dec 31, 2022-$97.48M–
FY2021Dec 31, 2021-$100.49M–
FY2020Dec 31, 2020-$99.98M–
FY2019Dec 31, 2019-$69.25M–
FY2018Dec 31, 2018-$39.48M–
FY2017Dec 31, 2017-$16.77M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$21.53M–
Q1 FY2026Mar 31, 2026-$18.43M–
Q4 FY2025Dec 31, 2025-$14.46M–
Q3 FY2025Sep 30, 2025-$18.00M–
Q2 FY2025Jun 30, 2025-$14.72M–
Q1 FY2025Mar 31, 2025-$13.11M–
Q4 FY2024Dec 31, 2024-$16.82M–
Q3 FY2024Sep 30, 2024-$19.76M–
Q2 FY2024Jun 30, 2024-$13.38M–
Q1 FY2024Mar 31, 2024-$9.28M–
Q4 FY2023Dec 31, 2023-$11.71M–
Q3 FY2023Sep 30, 2023-$8.49M–
Q2 FY2023Jun 30, 2023-$473.00K–
Q1 FY2023Mar 31, 2023-$20.29M–
Q4 FY2022Dec 31, 2022-$23.67M–
Q3 FY2022Sep 30, 2022-$16.50M–
Q2 FY2022Jun 30, 2022-$29.26M–
Q1 FY2022Mar 31, 2022-$28.05M–
Q4 FY2021Dec 31, 2021-$26.75M–
Q3 FY2021Sep 30, 2021-$25.09M–
Q2 FY2021Jun 30, 2021-$21.19M–
Q1 FY2021Mar 31, 2021-$27.45M–
Q4 FY2020Dec 31, 2020-$30.57M–
Q3 FY2020Sep 30, 2020-$24.89M–
Q2 FY2020Jun 30, 2020-$21.51M–
Q1 FY2020Mar 31, 2020-$23.01M–
Q4 FY2019Dec 31, 2019-$19.35M–
Q3 FY2019Sep 30, 2019-$13.46M–
Q2 FY2019Jun 30, 2019-$18.37M–
Q1 FY2019Mar 31, 2019-$18.08M–
Q4 FY2018Dec 31, 2018-$11.93M–
Q3 FY2018Sep 30, 2018-$12.90M–
Q2 FY2018Jun 30, 2018-$8.41M–
Q1 FY2018Mar 31, 2018-$6.24M–
Q4 FY2017Dec 31, 2017-$8.91M–
Q3 FY2017Sep 30, 2017-$3.34M–

More Tectonic Therapeutic figures

See a number that looks wrong?